Sacroiliitis as an Initial Manifestation of Acute Myelogenous Leukemia

被引:1
作者
Takumi Hoshino
Takafumi Matsushima
Yasuyuki Saitoh
Arito Yamane
Makiko Takizawa
Hiroyuki Irisawa
Takayuki Saitoh
Hiroshi Handa
Norifumi Tsukamoto
Masamitsu Karasawa
Hirokazu Murakami
Yoshihisa Nojima
机构
[1] Gunma University Graduate School of Medicine,Department of Medicine and Clinical Science
[2] Gunma University,School of Health Sciences Faculty of Medicine
[3] Gunma University Hospital,Division of Blood Transfusion Service
来源
International Journal of Hematology | 2006年 / 84卷
关键词
Sacroiliitis; AML; AS;
D O I
暂无
中图分类号
学科分类号
摘要
Sacroiliitis is the most pathognomonic and earliest manifestation of ankylosing spondylitis.We herein report a 28-year-old female patient who presented with sacroiliitis as an initial manifestation of acute myelogenous leukemia (AML). She had a 3-month history of anemia and walking difficulty. Bone marrow findings revealed an increase of blasts with trilineage dysplasia. Although she was initially diagnosed with myelodysplastic syndrome (MDS), blasts rapidly increased and AML developed 1 month after the diagnosis of MDS with sacroiliitis. Induction chemotherapy failed to induce a complete remission of AML, but it did effectively treat the sacroiliitis. However, the sacroiliitis relapsed when the leukemia cells progressed thereafter. Oral corticosteroids helped ameliorate the sacroiliitis. She underwent bone marrow transplantation (BMT) from an HLA-identical sister during a nonremission period; however, the leukemic cells began to rapidly increase from day 30 after BMT. The close relationship between the occurrence of sacroiliitis and AML suggested that autoimmune sacroiliitis was a paraneoplastic phenomenon of AML in this patient. Although autoimmune disorders develop in a substantial number of MDS patients, they are rarely observed in de novo AML. No previous report has described sacroiliitis as the initial manifestation of de novo AML.
引用
收藏
页码:421 / 424
页数:3
相关论文
共 50 条
[41]   Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia [J].
Shah, Mithun Vinod ;
Barochia, Amit ;
Loughran, Thomas P., Jr. .
IMPACT OF GENETIC TARGETS ON CANCER THERAPY, 2013, 779 :405-437
[42]   Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient [J].
Ikeda, Y ;
Sakemi, T ;
Matsuzaki, M ;
Sano, M .
INTERNAL MEDICINE, 2002, 41 (09) :722-724
[43]   Connexin-based signaling in acute myelogenous leukemia (AML) [J].
Foss, Brynjar ;
Tronstad, Karl Johan ;
Bruserud, Oystein .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2010, 1798 (01) :1-8
[44]   Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome [J].
Hitzler, Johann K. ;
He, Wensheng ;
Doyle, John ;
Cairo, Mitchell ;
Camitta, Bruce M. ;
Chan, Ka Wah ;
Perez, Miguel A. Diaz ;
Fraser, Christopher ;
Gross, Thomas G. ;
Horan, John T. ;
Kennedy-Nasser, Alana A. ;
Kitko, Carrie ;
Kurtzberg, Joanne ;
Lehmann, Leslie ;
O'Brien, Tracey ;
Pulsipher, Michael A. ;
Smith, Franklin O. ;
Zhang, Mei-Jie ;
Eapen, Mary ;
Carpenter, Paul A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) :893-897
[45]   Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission [J].
Bashir, Qaiser ;
Andersson, Borje S. ;
Fernandez-Vina, Marcelo ;
Silva, Leandro de Padua ;
Giralt, Sergio ;
Chiattone, Alexandre ;
Wei, Wei ;
Sharma, Manish ;
Anderlini, Paolo ;
Shpall, Elizabeth J. ;
Popat, Uday ;
Rodrigues, Morgani ;
Champlin, Richard E. ;
de Lima, Marcos .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) :1067-1071
[46]   Acute myelogenous leukemia stem cells: From Bench to Bedside [J].
Rico, J. Felipe ;
Hassane, Duane C. ;
Guzman, Monica L. .
CANCER LETTERS, 2013, 338 (01) :4-9
[47]   Personalized medicine in hematology using the example of acute myelogenous leukemia [J].
Ruecker, Frank G. ;
Bullinger, Lars .
MEDIZINISCHE GENETIK, 2016, 28 (04) :435-442
[48]   Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia [J].
Ge, Ling ;
Ye, Fan ;
Mao, Xinliang ;
Chen, Jia ;
Sun, Aining ;
Zhu, Xiaming ;
Qiu, Huiying ;
Jin, Zhengming ;
Miao, Miao ;
Fu, Chengcheng ;
Ma, Xiao ;
Chen, Feng ;
Xue, Shengli ;
Ruan, Changgeng ;
Wu, Depei ;
Tang, Xiaowen .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (07) :1040-1047
[49]   Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia [J].
Parkin, Brian ;
Ouillette, Peter ;
Li, Yifeng ;
Keller, Jennifer ;
Lam, Cindy ;
Roulston, Diane ;
Li, Cheng ;
Shedden, Kerby ;
Malek, Sami N. .
BLOOD, 2013, 121 (02) :369-377
[50]   Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia [J].
Drabkin, H ;
Parsy, C ;
Ferguson, K ;
Guilhot, F ;
Lacotte, L ;
Roy, L ;
Zeng, C ;
Baron, A ;
Hunger, SP ;
Varella-Garcia, M ;
Gemmill, R ;
Brizard, F ;
Brizard, A ;
Roche, J .
LEUKEMIA, 2002, 16 (02) :186-195